LatchBio

Executive Summary

LatchBio is a San Francisco-based biotechnology software company founded in 2020 that provides a unified, cloud-based data analysis platform tailored for life sciences R&D. Its modular platform integrates wet and dry lab operations by offering scalable compute, workflow orchestration, and interactive visualization tools specifically designed for biological data. By enabling reproducible, IND-ready analyses, LatchBio accelerates time-to-insight for biopharma companies, R&D labs, and solution providers such as kit and instrument manufacturers. The platform addresses critical bottlenecks in biological data management and analysis, positioning LatchBio as a key enabler in the shift toward cloud-native, AI-driven drug discovery and development. With increasing adoption of multi-omics and large-scale datasets, the company is well-positioned to capture a growing share of the life sciences software market, estimated to exceed $50 billion by 2030.

Upcoming Catalysts (preview)

• Q3 2026Series B/C Funding Round70% success
• Q4 2026Major Pharmaceutical Partnership60% success
• Q2 2026Launch of AI-Driven Analysis Module80% success